<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 3</issue_number>
<issue_period>2015 (July - September)</issue_period>
<title>ASSESSMENT OF ANTINEOPLASTIC POTENTIAL OF ANNONA MURICATA LINN. IN HUMAN CANCER CELL LINES </title>
<abstract> lessThan i greaterThan Annona  lessThan /i greaterThan produces a novel set of chemicals called annonaceous acetogenins, known to possess antineoplastic activity.The present study was undertaken to establish the antineoplastic potential of  lessThan i greaterThan Annona muricata  lessThan /i greaterThan by MTT, Cell cycle (G2M) and DNA fragmentation assays. The extracts showed dose dependant growth inhibition of SCC9 (oral cancer), MCF-7 (Breast cancer), A549 (Lung Cancer) and HCT116 (Colorectal Cancer) cells. In contrast to HCT116 cells, the treated SCC9, MCF-7 and A549 cells exhibited significant cytotoxicity at a higher concentration with IC50 value of 87.8, 151.6 and 230.6 respectively. The treated SCC9 and MCF-7cells showed cell cycle arrest up to 27.97% and 19.42% respectively, at G2/M phase of the cell cycle. DNA degradation observed in both MCF-7 and SCC9 cells treated with  lessThan i greaterThan A.muricata extract  lessThan /i greaterThan at a concentration of 320µg/ml suggest that it might induce apoptosis in both MCF-7 and SCC9 cells.</abstract>
<authors>RAJARAJAN.P AND SENTHILKUMAR.R</authors>
<keywords>Annona muricata, Antineoplastic activity, MTT, G2M and DNA fragmentation</keywords>
<pages>1101-1109</pages>
</article>
</Journal>
